Agop Y. Bedikian, MD
M.D. Anderson Cancer Center
4
3
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Antoni Ribas, MD
University of California, Los Angeles
Shared therapeutic areas:
Worked with same sponsors:
Lee Cranmer, M.D.
University of Arizona
Shared therapeutic areas:
Worked with same sponsors:
John Kirkwood, M.D.
University of Pittsburgh
Shared therapeutic areas:
Worked with same sponsors:
Andres Forero, M.D.
University of Alabama at Birmingham
Shared therapeutic areas:
Worked with same sponsors:
Steven J. O'Day, M.D.
Cancer Institute Medical Group, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Colin P. Curran, M.D.
Palmetto Hematology Oncology, P.C.
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Deborah E Citrin, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
William D Figg, Pharm.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Worked with same sponsors:
Jamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
All 4 trials loaded